On November 1, the Bureau of Na-tional Health Insurance launched the largest-ever single wave of reductions in its standardized payments for medicines. Involving a total of over 5,300 products, the reductions average about 10 %, and are expected to save NT $ 7-9 billion a year in expenditures on pharmaceuticals. At the same time, the co-payment that outpatients bear for the cost of their medications will be reduced.
中央健保局歷年來最大一波的藥價給付標準調降措施，於 11 月 1 日正式上路，總計涉及五千三百多項藥品，調幅平均 10 %，預計每年將節省 70 到 90 億元的健保藥費支出，民眾看病拿藥的部分負擔金額也將同步減少。